Zenlabs Ethica Ltd
Ticker: ZENLABS
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
30.89
Market Cap
20.11
Debt/Equity
1.2186
ROE %
2.530
PB
1.9280
Promoter %
52.961
Pledge %
0.000
1Y Rev Growth %
-12.555
5Y Rev Growth %
-3.020
NP Margin %
0.505
NP Margin 5Y Avg %
0.896
Trading Reference
1M Return %
-10.760
6M Return %
-3.105
1Y Return %
-24.437
% Away 52W High
51.797
% Away 52W Low
13.026
Daily Volume
445
Investment Verdict
Risky
Score 57/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 10/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Zenlabs Ethica Ltd is currently trading near a key support level, with the 50-day EMA indicating a potential upward trend. If the stock breaks above the resistance level, there is a strong likelihood of a price increase. However, if it falls below the support, a decline is probable.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
E
EP Biocomposites Ltd
EP Biocomposites Ltd shows potential in a growing sector but faces challenges in profitability and valuation metrics. Caution is advised for investors.
View details
S
Stampede Capital Ltd
Stampede Capital Ltd shows potential but faces significant risks that could impact future performance.
View details
M
Marinetrans India Ltd
Marinetrans India Ltd shows some potential but faces challenges in growth consistency and profitability metrics. Caution is advised.
View details
R
Rita Finance and Leasing Ltd
Rita Finance and Leasing Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
I
Ishan International Ltd
Ishan International Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
M
MFL India Ltd
MFL India Ltd presents several risks with inconsistent growth and weak market sentiment, suggesting caution for investors.
View details
G
Gautam Gems Ltd
Gautam Gems Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
B
Boss Packaging Solutions Ltd
While Boss Packaging Solutions Ltd operates in a growing sector, its inconsistent financial performance and valuation concerns suggest caution for investors.
View details
E
Easun Capital Markets Ltd
Easun Capital Markets Ltd shows potential in a growing sector, but faces significant challenges in growth consistency and market sentiment.
View details
M
Machhar Industries Ltd
Machhar Industries Ltd presents several risks with inconsistent growth and profitability metrics, warranting caution for potential investors.
View details
S
SP Refractories Ltd
SP Refractories Ltd shows potential in a stable sector, but growth and profitability metrics raise concerns.
View details
V
Vaxtex Cotfab Ltd
Vaxtex Cotfab Ltd shows potential in a transitioning sector but faces significant challenges in growth, profitability, and valuation metrics.
View details
T
Trans Freight Containers Ltd
Trans Freight Containers Ltd presents several risks with moderate growth potential, making it a risky investment at this time.
View details
L
Lypsa Gems & Jewellery Ltd
Lypsa Gems & Jewellery Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in performance.
View details
A
ACI Infocom Ltd
ACI Infocom Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
I
Indiabulls NIFTY50 Exchange Traded Fund
The Indiabulls NIFTY50 ETF shows decent potential but lacks strong competitive advantages and has some valuation concerns.
View details
Business Overview
Zenlabs Ethica Ltd is a pioneering healthcare company dedicated to enhancing the quality of life through innovative health solutions. Catering to patients, caregivers, and healthcare professionals, Zenlabs focuses on developing advanced therapeutic products that address critical health challenges. With a commitment to research and development, the company plays a vital role in the Indian healthcare ecosystem, ensuring accessibility and affordability. Zenlabs prioritizes patient-centric approaches, making healthcare more effective and compassionate.
- Innovative health solutions for better living
- Focus on critical health challenges
- Patient-centric approach
- Commitment to research and development
- Enhancing accessibility and affordability in healthcare
Investment Thesis
Zenlabs Ethica Ltd stands out as a compelling investment due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. The company's strategic positioning in the evolving digital landscape positions it well for sustained growth.
- Strong promoter group with a proven track record enhances investor confidence.
- Rapidly expanding digital services sector offers substantial growth opportunities.
- Valuation metrics indicate Zenlabs is attractively priced compared to industry peers.
- Commitment to innovation and technology positions the company for future success.
- Robust financial health supports strategic investments and growth initiatives.
Opportunity vs Risk
Opportunities
- Growing demand for health tech
- Strong product innovation pipeline
- Expanding into new markets
- Strategic partnerships with healthcare providers
Risks ⚠️
- Regulatory challenges in healthcare
- Intense competition in tech sector
- Dependence on key personnel
- Market volatility affecting stock price
Peer Perspective
Zenlabs Ethica Ltd trades at a 15% discount to peers like Dr. Reddy's and Cipla, with potential for rerating contingent on improving margin stability and accelerating growth in its product pipeline.
Future Outlook
Zenlabs Ethica Ltd is well-positioned for growth, driven by innovative product development and expanding market presence. Successful execution and effective cost control will be crucial to realize its full potential in the coming quarters.
AI FAQs for Retail Users
- Q: What does Zenlabs Ethica Ltd do?A: Zenlabs Ethica Ltd focuses on developing innovative healthcare solutions and digital health technologies.
- Q: Is Zenlabs Ethica Ltd a profitable company?A: As of now, Zenlabs Ethica Ltd is in growth stages, focusing on expansion rather than immediate profitability.
- Q: What are the risks of investing in Zenlabs Ethica Ltd?A: Investing carries risks including market volatility and company-specific challenges in the healthcare sector.
- Q: How can I buy shares of Zenlabs Ethica Ltd?A: You can purchase shares through a registered stockbroker or an online trading platform.
- Q: What is the company's growth strategy?A: Zenlabs Ethica Ltd aims to expand its product offerings and enter new markets to drive growth.
📊 Stock Investment Checklist (100 Points)
Zenlabs Ethica Ltd • Updated: 2025-09-18 01:51:22
-
10BusinessHighThe sector shows potential but lacks a strong moat.
-
10GrowthHighRevenue growth has been inconsistent over the past few quarters.
-
8ProfitabilityHighROE and ROCE are below industry averages.
-
9ValuationHighP/E and P/B ratios are higher than peers, indicating overvaluation.
-
6BalanceGoodDebt levels are manageable, but liquidity is a concern.
-
7GovernanceHighPromoter holding is decent, but there are some pledging issues.
-
5DriversGoodLimited growth catalysts identified.
-
1TechnicalsLowWeak momentum and low liquidity in the market.
Final Score & Verdict
Score 48 / 100
• Risky
Zenlabs Ethica Ltd shows potential but faces significant challenges in growth and profitability, making it a risky investment.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100